Skip to main content
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1972 Jun;1(6):489–495. doi: 10.1128/aac.1.6.489

Enhanced Toxicity for Mice of Vincristine and Other Chemotherapeutic Agents with Salmonella typhosa Endotoxin and Pseudomonas aeruginosa

W C Rose 1,2, S G Bradley 1,2, I P Lee 1,2
PMCID: PMC444248  PMID: 4218944

Abstract

The toxicity of Salmonella typhosa 0901 W endotoxin for BALB/c mice was potentiated by the administration of 375 mg of cyclophosphamide per kg, 16 mg of daunomycin per kg, 80 mg of methotrexate per kg, 8 mg of pactamycin per kg, 20 mg of polyinosinic-polycytidylic acid per kg, 1,000 mg of procarbazine per kg, and 1 or 4 mg of vincristine per kg. l-Asparaginase (20,000 units per kg) failed to potentiate endotoxin. Sedation following administration of 45 mg of pentobarbital per kg was prolonged in mice that had received 20,000 units of l-asparaginase per kg, 4 mg of daunomycin per kg, 120 mg of methotrexate per kg, 8 mg of pactamycin per kg, 10 mg of polyinosinic-polycytidylic acid per kg, 500 mg of procarbazine per kg, 2 mg of vincristine per kg, 2 mg of endotoxin per kg, or multiple doses of endotoxin. Mice pretreated with multiple endotoxin doses experienced a significant reduction in their lethal responses due to vincristine-endotoxin combinations; however, endotoxin-pretreated mice were more susceptible to vincristine alone than were normal mice. Simultaneous administration of 1 or 2 mg of vincristine per kg and 1 mg of endotoxin per kg produced greater lethality than sequential regimens. Pretreatment of mice with 65 mg of phenobarbital per kg on 4 consecutive days protected against vincristine-endotoxin combinations. Liver homogenates prepared from mice exposed previously to vincristine were capable of inactivating endotoxin. Vincristine lethality was increased by simultaneous administration of heat-killed cells of Pseudomonas aeruginosa isolated from mouse feces.

Full text

PDF
489

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bhuyan B. K. Pactamycin, an antibiotic that inhibits protein synthesis. Biochem Pharmacol. 1967 Aug;16(8):1411–1420. doi: 10.1016/0006-2952(67)90116-5. [DOI] [PubMed] [Google Scholar]
  2. Dowling J. N., Feldman H. A. Quantitative biological assay of bacterial endotoxins. Proc Soc Exp Biol Med. 1970 Jul;134(3):861–864. doi: 10.3181/00379727-134-34899. [DOI] [PubMed] [Google Scholar]
  3. Filkins J. P. Hepatic lysosomes and the inactivation of endotoxin. J Reticuloendothel Soc. 1971 May;9(5):480–490. [PubMed] [Google Scholar]
  4. Pieroni R. E., Broderick E. J., Bundeally A., Levine L. A simple method for the quantitation of submicrogram amounts of bacterial endotoxin. Proc Soc Exp Biol Med. 1970 Mar;133(3):790–794. doi: 10.3181/00379727-133-34565. [DOI] [PubMed] [Google Scholar]
  5. Robinson S. H., Rugstad H. E., Yannoni C., Tashjian A. H., Jr Labeled bilirubin production by a clonal strain of rat hepatoma cells. Proc Soc Exp Biol Med. 1971 Mar;136(3):684–686. doi: 10.3181/00379727-136-35340. [DOI] [PubMed] [Google Scholar]
  6. Rose W. C., Bradley S. G. Enhanced toxicity for mice of combinations of antibiotics with Escherichia coli cells or Salmonella typhosa endotoxin. Infect Immun. 1971 Nov;4(5):550–555. doi: 10.1128/iai.4.5.550-555.1971. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. SCHAEDLER R. W., DUBOS R. J. The fecal flora of various strains of mice. Its bearing on their susceptibility to endotoxin. J Exp Med. 1962 Jun 1;115:1149–1160. doi: 10.1084/jem.115.6.1149. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Whitecar J. P., Jr, Luna M., Bodey G. P. Pseudomonas bacteremia in patients with malignant diseases. Am J Med Sci. 1970 Oct;60(4):216–223. doi: 10.1097/00000441-197010000-00003. [DOI] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES